238 related articles for article (PubMed ID: 11427792)
1. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of
Singal M; Mahmoud A; Phatak PD
Expert Rev Hematol; 2024; 17(4-5):145-152. PubMed ID: 38551816
[TBL] [Abstract][Full Text] [Related]
3. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
Fargion S; Piperno A; Cappellini MD; Sampietro M; Fracanzani AL; Romano R; Caldarelli R; Marcelli R; Vecchi L; Fiorelli G
Hepatology; 1992 Dec; 16(6):1322-6. PubMed ID: 1359994
[TBL] [Abstract][Full Text] [Related]
5. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda.
Edwards CQ; Griffen LM; Goldgar DE; Skolnick MH; Kushner JP
Gastroenterology; 1989 Oct; 97(4):972-81. PubMed ID: 2789160
[TBL] [Abstract][Full Text] [Related]
6. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins.
Whitfield JB; Cullen LM; Jazwinska EC; Powell LW; Heath AC; Zhu G; Duffy DL; Martin NG
Am J Hum Genet; 2000 Apr; 66(4):1246-58. PubMed ID: 10739755
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda.
DeCastro M; Sánchez J; Herrera JF; Cháves A; Durán R; García-Buey L; García-Monzón C; Sequí J; Moreno-Otero R
Hepatology; 1993 Apr; 17(4):551-7. PubMed ID: 7682979
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda (PCT).
Piperno A; D'Alba R; Roffi L; Pozzi M; Farina A; Vecchi L; Fiorelli G
Arch Virol Suppl; 1992; 4():215-6. PubMed ID: 1360288
[TBL] [Abstract][Full Text] [Related]
9. Biological variability of transferrin saturation and unsaturated iron-binding capacity.
Adams PC; Reboussin DM; Press RD; Barton JC; Acton RT; Moses GC; Leiendecker-Foster C; McLaren GD; Dawkins FW; Gordeuk VR; Lovato L; Eckfeldt JH
Am J Med; 2007 Nov; 120(11):999.e1-7. PubMed ID: 17976429
[TBL] [Abstract][Full Text] [Related]
10. Interactive Effects between Chronic Lead Exposure and the Homeostatic Iron Regulator Transport
Chen CJ; Lin TY; Wang CL; Ho CK; Chuang HY; Yu HS
Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30691187
[TBL] [Abstract][Full Text] [Related]
11.
Lucas MR; Atkins JL; Pilling LC; Shearman JD; Melzer D
BMJ Open; 2024 Mar; 14(3):e081926. PubMed ID: 38479735
[TBL] [Abstract][Full Text] [Related]
12. Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt.
Barton JC; Barton JC; Acton RT
Mol Genet Genomic Med; 2024 Jan; 12(1):e2321. PubMed ID: 37930135
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda.
Kushner JP; Edwards CQ; Dadone MM; Skolnick MH
Gastroenterology; 1985 May; 88(5 Pt 1):1232-8. PubMed ID: 3979748
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.
Sartori M; Andorno S; Pagliarulo M; Rigamonti C; Bozzola C; Pergolini P; Rolla R; Suno A; Boldorini R; Bellomo G; Albano E
Gut; 2007 May; 56(5):693-8. PubMed ID: 17135308
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic expression of the HLA linked iron-loading gene in males over the age of 40 years: a population study using serial serum ferritin estimations.
Meyer T; Baynes R; Bothwell T; Jenkins T; Jooste P; Du Toit E; Martell R; Jacobs P
J Intern Med; 1990 Jun; 227(6):397-406. PubMed ID: 1972175
[TBL] [Abstract][Full Text] [Related]
16. Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study.
Adams P; Barton JC; McLaren GD; Acton RT; Speechley M; McLaren CE; Reboussin DM; Leiendecker-Foster C; Harris EL; Snively BM; Vogt T; Sholinsky P; Thomson E; Dawkins FW; Gordeuk VR; Eckfeldt JH
Can J Gastroenterol; 2009 Nov; 23(11):769-72. PubMed ID: 19893773
[TBL] [Abstract][Full Text] [Related]
17. Porphyria cutanea tarda in Scotland: underlying associations and treatment approaches.
Chaiyabutr C; Dawe R; Ibbotson SH; Clarke T; McGuire VA
Int J Dermatol; 2024 Apr; ():. PubMed ID: 38647187
[TBL] [Abstract][Full Text] [Related]
18. Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
McLaren CE; Gordeuk VR; Chen WP; Barton JC; Acton RT; Speechley M; Castro O; Adams PC; Snively BM; Harris EL; Reboussin DM; McLachlan GJ; Bean R;
Transl Res; 2008 Feb; 151(2):97-109. PubMed ID: 18201677
[TBL] [Abstract][Full Text] [Related]
19. Porphyria cutanea tarda and haemochromatosis: a family study.
Seymour DG; Elder GH; Fryer A; Jacobs A; Williams GT
Gut; 1990 Jun; 31(6):719-21. PubMed ID: 2379879
[TBL] [Abstract][Full Text] [Related]
20. Early presentation of adult-onset conditions: A dual diagnosis of hereditary hemochromatosis and porphyria cutanea tarda.
Strong A; Keller K; Merves J
Mol Genet Metab Rep; 2020 Dec; 25():100638. PubMed ID: 32874917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
